Publishing schedule 2019

 

No.

Issued

Booking and Material

Themes

 

  

Products

Recruit

  

1-2

11.1. 

2.1. 

7.1. 

New drugs and innovations

 

3

25.1.

15.1. 

21.1.

Diabetes

 

*4

1.2.

22.1.

28.1.

Oncology and hematologic diseases

 

5

8.2.

30.1.

4.2.

Infections

 

*6-7

15.2.

5.2.

11.2.

Neurology

 

8

1.3.

19.2.

25.2.

Rheumatic diseases

 

9-10

8.3.

26.2.

4.3.

Psychiatry

 

11

22.3. 

12.3. 

18.3. 

Asthma and allergies

 

12

29.3.

19.3. 

25.3.

Cardiovascular diseases, research issue

 

13

5.4.

26.3.

1.4. 

Dermatology

 

*14-15

12.4.

2.4.

8.4.

Diabetes

 

16

26.4.

16.4.

18.4.

Bowel diseases

 

17

3.5.

23.4.

26.4.

Vaccines

 

18

10.5.

30.4. 

6.5.

Neurology

 

19

17.5. 

7.5.

13.5.

Health technology

 

*20-21

24.5.

14.5.

20.5.

Infections

 

22

7.6. 

28.5. 

3.6. 

Lung diseases

 

23-24

14.6.

4.6.

10.6.

Oncology and hematologic diseases, research issue

 

*25

16.8.

6.8.

12.8. 

New drugs and innovations

 

26

23.8. 

13.8.

19.8.

Anaesthesia and intensive care

 

27

30.8. 

20.8. 

26.8. 

Schizophrenia

 

28

6.9.

27.8.

2.9.

Oncology and hematologic diseases

 

29 

13.9. 

3.9.

9.9.

Infections

 

30

20.9. 

10.9. 

16.9. 

Neurology

 

31

27.9. 

17.9. 

23.9. 

Diabetes, research issue

 

*32

4.10. 

24.9. 

30.9. 

Vaccines

 

33

11.10. 

1.10. 

7.10. 

Rheumatic diseases

 

34

18.10. 

8.10. 

14.10. 

Lung diseases, research issue

 

*35

25.10. 

15.10. 

21.10.

Bowel diseases
 

36

1.11. 

22.10.

28.10.

Gynaecology

37

8.11.

29.10.

4.11. 

Infections

 

*38

15.11. 

5.11. 

11.11. 

Pain

 

39-40

22.11.

12.11.

18.11.

Oncology and hematologic diseases

 

41

5.12.

26.11.

29.11. 

Cardiovascular diseases

 

42-43

13.12. 

3.12.

9.12.

100 opinion leaders

 
*Extra distribution to The Finnish Pharmacists' Society (circa 1.100 pcs)

Publishing schedule 2020

 

No.

Issued

Booking and Material

Themes

 

 

 

Products

Recruit

  

1-2

10.1. double

30.12.

3.1.

New drugs and innovations

 

3

24.1.

14.1.

20.1.

Psychiatry and recruiting

 

4

31.1.

21.1.

27.1.

Asthma

 

5

7.2.

28.1.

3.2.

Cardiovascular diseases

 

6-7

14.2. double

4.2.
10.2.

Infection

 

8

28.2.

18.2.

24.2.

Neurology

 

9

6.3.

25.2.

2.3.

Autoimmune diseases

 

10

13.3.

3.3.

9.3.

Diabetes

 

11

20.3.
10.3.
16.3.
Vaccines
 

12

27.3.

17.3.

23.3.

Allergy

 

13-14

3.4. double

24.3.
30.3.

Dermatology

 

15

17.4.
3.4.
8.4.
Accident and Emergency medicine
 

16-17

24.4. double

14.4.
20.4.
Bowel diseases
 

18

8.5.
27.4.
4.5.
Diabetes
 

19-20

15.5. double

5.5.
11.5.
Neurology and MS disease
 

21

29.5.
18.5.
25.5.

Health technology

 

22

5.6.
26.5.
1.6.
Lung diseases
 

23-24

12.6. double
2.6.
8.6.

Oncology and hematologic diseases

 

25

14.8.
4.8.
10.8.
New drugs and innovations
 

26

21.8.
11.8.
17.8.
Anaesthesia and intensive care, recruiting
 

27

28.8.
18.8.
24.8.
Depression
 

28

4.9.
25.8.
31.8.
Asthma
 

29

11.9.
1.9.
7.9.
Infections
 

30

18.9.
8.9.
14.9.
Neurology
 

31

25.9.
15.9.
21.9.

Diabetes

 
32
2.10.22.9.
28.9.
Vaccines

 

33-34

9.10. double
29.9.
5.10.
Rheumatic diseases
 

35

23.10.
13.10.
19.10.

Lung diseases

 

36

30.10.
20.10.
26.10.
Bowel diseases
 

37

6.11.
27.10.
2.11.Gyneacology

38

13.11.

3.11.

9.11.

Schizophrenia

 

39

20.11.

10.11.

16.11.

Pain and migraine

 

40

27.11.
17.11.23.11.
Oncology and hematologic diseases
 

41

4.12.

24.11.
30.11.
Cardiovascular diseases
 

42-43

11.12. double
1.12.
7.12.
100 influencers